Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

SERD

A drug that binds to and breaks down proteins called estrogen receptors (ERs), which are found inside the cells of female reproductive tissue, breast tissue, and other types of tissue, and some cancer cells. These drugs keep the hormone estrogen from binding to the ERs inside the cells and block the effects of estrogen in the body. Some breast cancer cells and other types of cancer cells have ERs and may need estrogen to grow. Treatment with SERDs may keep these cancer cells from growing. Examples of SERDs that have been approved to treat some types of breast cancer are fulvestrant and elacestrant. Also called selective estrogen receptor degrader.
More Information
Search NCI's Dictionary of Cancer Terms